12 HR Nucynta 250 MG Extended Release Oral Tablet
- RxCUI
- 1149376
- RxNorm name
- 12 HR Nucynta 250 MG Extended Release Oral Tablet
- Display name
- 12 HR Nucynta 250 MG Extended Release Oral Tablet
- Full name
- 12 HR Nucynta 250 MG Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nucynta ER | TAPENTADOL HYDROCHLORIDE | Collegium Pharmaceutical, Inc. | c3d04d70-0155-4147-9ce4-a3b1fad4b373 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 1149376 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c3d04d70-0155-4147-9ce4-a3b1fad4b373 | 12 HR Nucynta 250 MG Extended Release Oral Tablet | SY | 8 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20251230 |
| c3d04d70-0155-4147-9ce4-a3b1fad4b373 | 12 HR tapentadol 250 MG Extended Release Oral Tablet [Nucynta] | SBD | 8 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20251230 |
| c3d04d70-0155-4147-9ce4-a3b1fad4b373 | Nucynta 250 MG (tapentadol hydrochloride 291.20 MG) 12 HR Extended Release Oral Tablet | SY | 8 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20251230 |
| c3d04d70-0155-4147-9ce4-a3b1fad4b373 | Nucynta ER 250 MG 12HR Extended Release Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20251230 |
| 40671852-846e-4bc1-8e15-1f71add24414 | 12 HR Nucynta 250 MG Extended Release Oral Tablet | SY | 5 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20181022 |
| 40671852-846e-4bc1-8e15-1f71add24414 | 12 HR tapentadol 250 MG Extended Release Oral Tablet [Nucynta] | SBD | 5 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20181022 |
| 40671852-846e-4bc1-8e15-1f71add24414 | Nucynta ER 250 MG 12HR Extended Release Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20181022 |
| 40671852-846e-4bc1-8e15-1f71add24414 | Nucynta 250 MG (tapentadol hydrochloride 291.20 MG) 12 HR Extended Release Oral Tablet | SY | 5 | These highlights do not include all the information needed to use NUCYNTA ® ER safely and effectively. See full prescribing information for NUCYNTA ® ER NUCYNTA ® ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008 | 20181022 |